MRSH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Marsh & McLennan Companies Inc (MRSH) is a good buy for a beginner investor with a long-term horizon and $50,000-$100,000 available for investment. Despite mixed analyst ratings and a recent sector selloff, the company's strong financial performance, positive acquisition news, and durable business model make it a solid investment opportunity. The stock's current pre-market price of $175.61 is near its pivot level, suggesting a reasonable entry point.
The MACD is positive and expanding, indicating potential upward momentum. However, the RSI is neutral at 48.91, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels are Pivot: 172.069, R1: 177.138, S1: 167, R2: 180.27, S2: 163.868. The stock is trading near its pivot level, which could act as a support zone.
Acquisition of AltamarCAM, adding €20 billion in assets under management.
Strong Q4 2025 financial performance with revenue up 8.70% YoY and net income up 4.19% YoY.
Positive sentiment from Barclays and Raymond James, highlighting the durability of the business model and AI's potential to enhance productivity.
Recent downgrades from Mizuho and concerns about AI-driven disruption in the insurance brokerage sector.
Bearish moving averages and neutral RSI suggest limited short-term momentum.
In Q4 2025, revenue increased by 8.70% YoY to $6.595 billion, net income rose by 4.19% YoY to $821 million, and EPS grew by 5.03% YoY to $1.67. Gross margin remained stable at 100%. These figures indicate consistent growth and profitability.
Analyst ratings are mixed. Barclays maintains an Overweight rating with a price target of $209, citing the selloff as overdone. Raymond James upgraded the stock to Strong Buy with a price target of $225, highlighting strong credit metrics and margin expansion. However, Mizuho downgraded the stock to Neutral with a price target of $199, citing limited disruption risk but concerns about sector-wide headwinds.
